Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 3, 1998, Pages 343-347

  Wenisch, Christoph ^a   Looareesuwan, Sornchai ^b   Wilairatana, Polrat ^b   Parschalk, Bernhard ^a   Vannapann, Suparp ^b   Wanaratana, Vara ^b   Wernsdorfer, Walther ^c   Graninger, Wolfgang ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CYTOKINE; INTERLEUKIN 6; PENTOXIFYLLINE; PLACEBO; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; THAILAND; TREATMENT OUTCOME;

EID: 0031923048     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.343     Document Type: Article

References (22)

1. Kern P, Hemmer CF, Gallati H, Neifer S, Kremsner P, Dietrich M, Porzsolt F, 1992. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 166: 930-934.
2. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH, 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
3. Rock EP, Roth EF, Rojas-Corona RR, 1988. Thrombospondin mediates the cytoadherence of Plasmodium falciparum-infected red cells to vascular endothelium in shear flow conditions. Blood 71: 71-75.
4. Oquendo P, Hundt E, Lawler J, Seed B, 1989. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58: 95-101.
5. Ockenhouse CF, Ho M, Tandon NN, 1991. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 164: 163-169.
6. Berendt AR, Simmons DI, Tansey J, Newbold CI, Marsh K, 1989. Intercellular adhesion molecule is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341: 57-59.
7. Ockenhouse CF, Tegochi T, Maeno Y, 1992. Human vascular cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 176: 1183-1189.
8. Thumwood CM, 1989. Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice. Brit J Exp Pathol 70: 293-303.
9. Kwiatkowski D, 1990. TNF concentration in fatal cerebral, nonfatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
10. Grau GE, 1987. Tumor necrosis factorcachectin as an essential mediator in murine cerebral malaria. Science 237: 1210-1212.
11. Taverne J, 1990. Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun 58: 2923-2928.
12. Stricter RM, Remick DG, Ward PAI, 1988. Cellular and molecular regulation of tumor necrosis factor release from macrophages. Biochem Biophys Res Comm 155: 1230-1236.
13. Sullivan GW, 1988. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function with pentoxifylline. Infect Immun 56: 1722-1729.
14. Ward A, Clissold SP, 1987. Pentoxifylline, a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34: 50-97.
15. Seiffge D, 1982. Effect of pentoxifylline on red cell aggregation. Med Sci 8: 727.
16. Graninger W, Thalhammer F, Locker G, 1991. Pentoxifylline in cerebral malaria. J Infect Dis 164: 829.
17. Kremsner PG, 1991. Pentoxifylline prevents murine cerebral malaria. J Infect Dis 164: 605-608.
18. Landau Z, Attali M, 1993. Use of pentoxifylline in the treatment of cerebral malaria. Clin Infect Dis 17: 137.
19. Moling O, Mian P, 1994. Use of pentoxifylline in the treatment of cerebral malaria. Clin Infect Dis 19: 558-559.
20. Di Perri G, Di Perri IG, Monteiro GB, Bonora S, Hennig C, Cassatella M, Micciolo R, Vento S, Dusi S, Bassetti D, Concia E, 1995. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infecl Dis 171: 1317-1322.
21. Looareesuwan S, Wilairatana P, Vannapann S, Wanaratana V, Wenisch C, Aikawa M, Brittenham G, Graninger W, Wernsdorfer W, 1998. Pentoxifylline as an ancillary treatment for severe falciparum malaria. Am J Trop Med Hyg 58: 348-353.
22. Urquhart AD, 1994. Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria. Clin Infect Dis 19: 117-131.